Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beacon for Rare Diseases, formerly known as Findacure, is a UK-based non-profit organization dedicated to transforming the rare disease landscape through drug repurposing and patient group empowerment. The organization acts as a catalyst in the life sciences sector by bridging the gap between patient communities, academic researchers, and the pharmaceutical industry to identify existing medicines that can be repurposed for rare conditions. Beacon provides training, networking, and collaborative platforms to help small patient groups become research-ready and professionalized. Their flagship initiatives include the RareRepurposing Partnership and various social impact investment models designed to fund clinical trials for neglected diseases. By focusing on drug repurposing, Beacon aims to deliver faster, cheaper, and lower-risk treatments to patients who currently have no therapeutic options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Find A Cure.